Sufentanil inhibits the proliferation and epithelial mesenchymal transition of lung cancer cells through Wnt/beta-catenin signaling pathway

References

• Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, Etiology and Prevention. Clin Chest Med. 2020;41(1):1–24.
   PubMed Web of Science ®Google Scholar
• Gao S, Li N, Wang S, et al. Lung cancer in People’s Republic of China. J Thorac Oncol. 2020;15(10):1567.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature (London). 2018;553(7689):446–454.
   PubMed Web of Science ®Google Scholar
• Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc. 2019;94(8):1623–1640.
   Google Scholar
• Hosomi Y, Morita S, Sugawara S, et al. Gefitinib alone versus gefitinib plus chemotherapy for non-small-cell lung cancer with mutated epidermal growth factor receptor: NEJ009 study. J Clin Oncol. 2020;38(2):115–123.
   PubMed Web of Science ®Google Scholar
• Wang L, Tong X, Zhou Z, et al. Circular RNA HSA_circ_0008305 (circPTK2) inhibits TGF-beta-induced epithelial-mesenchymal transition and metastasis by controlling TIF1gamma in non-small cell lung cancer. Mol Cancer. 2018;17(1):140.
   PubMed Web of Science ®Google Scholar
• Chae YK, Chang S, Ko T, et al. Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC. Sci Rep. 2018;8(1):2918.
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Mol Cell Biol. 2014;15(3):178–196.
   Google Scholar
• Zhang J, Ten DP, Wuhrer M, et al. Role of glycosylation in TGF-beta signaling and epithelial-to-mesenchymal transition in cancer. Protein Cell. 2021;12(2):89–106.
   PubMed Web of Science ®Google Scholar
• He R, Zhang FH, Shen N. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC. Biomed Pharmacother. 2017;95:331–338.
   PubMed Web of Science ®Google Scholar
• Sridharan K, Sivaramakrishnan G. Comparison of fentanyl, Remifentanil, Sufentanil and Alfentanil in combination with propofol for general anesthesia: a systematic review and meta-analysis of randomized controlled trials. Curr Clin Pharmacol. 2019;14(2):116–124.
   PubMed Web of Science ®Google Scholar
• Donk T, Ward S, Langford R, et al. Pharmacokinetics and pharmacodynamics of sublingual sufentanil for postoperative pain management. Anaesthesia. 2018;73(2):231–237.
   PubMed Web of Science ®Google Scholar
• Wu QL, Shen T, Ma H, et al. Sufentanil postconditioning protects the myocardium from ischemia-reperfusion via PI3K/Akt-GSK-3beta pathway. J Surg Res. 2012;178(2):563–570.
   PubMed Web of Science ®Google Scholar
• Wu W, Wei N, Jiang CN, et al. Effects of sufentanil on human gastric cancer cell line SGC-7901 in vitro. Cent Eur J Immunol. 2014;3:299–305.
   Web of Science ®Google Scholar
• Gu Z, Fang L, Ma P. The angiotensin-converting enzyme inhibitor, captopril, suppressed hepatic stellate cell activation via NF-kappaB or wnt3α/β-catenin pathway. Bioengineered. 2021;12(1):8370–8377.
   PubMed Web of Science ®Google Scholar
• Lu X, Gao H, Zhu B, et al. Circular RNA circ_RANBP9 exacerbates polycystic ovary syndrome via microRNA-136-5p/ XIAP axis. Bioengineered. 2021;12(1):6748–6758.
   PubMed Web of Science ®Google Scholar
• Shan Y, Li Y, Han H, et al. Insulin reverses choriocarcinoma 5- fluorouracil resistance. Bioengineered. 2021;12(1):2087–2094.
   PubMed Web of Science ®Google Scholar
• Yuan G, Ding W, Sun B, et al. Upregulated circRNA_102231 promotes gastric cancer progression and its clinical significance. Bioengineered. 2021;12(1):4936–4945.
   PubMed Web of Science ®Google Scholar
• Xiao R, Wang H, Yang B. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway. Bioengineered. 2021;12(2):10596–10607.
   PubMed Web of Science ®Google Scholar
• Guan S, Jin T, Han S, et al. Dihydroartemisinin alleviates morphine-induced neuroinflammation in BV-2 cells. Bioengineered. 2021;12(2):9401–9410.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhang Z, Xu H, et al. Lidocaine alleviates cytotoxicity-resistance in lung cancer A549/DDP cells via down-regulation of miR-21. Mol Cell Biochem. 2019;456(1–2):63–72.
   PubMed Web of Science ®Google Scholar
• Li R, Xiao C, Liu H, et al. Effects of local anesthetics on breast cancer cell viability and migration. BMC CANCER. 2018;18(1):666.
   PubMed Web of Science ®Google Scholar
• Zhao L, Li Y. Application of dexmedetomidine combined with sufentanil in colon cancer resection and its effect on immune and coagulation function of patients. Oncol Lett. 2020;20(2):1288–1294.
   PubMed Web of Science ®Google Scholar
• Tang C, Hu Y, Zhang Z, et al. Dexmedetomidine with sufentanil in intravenous patient-controlled analgesia for relief from postoperative pain, inflammation and delirium after esophageal cancer surgery. Biosci Rep. 2020;40(5):BSR20193410.
   PubMed Web of Science ®Google Scholar
• Gong R, Lin W, Gao A, et al. Forkhead box C1 promotes metastasis and invasion of non–small cell lung cancer by binding directly to the lysyl oxidase promoter. Cancer Sci. 2019;110(12):3663–3676.
   PubMed Web of Science ®Google Scholar
• Perlikos F, Harrington KJ, Syrigos KN. Key molecular mechanisms in lung cancer invasion and metastasis: a comprehensive review. Crit Rev Oncol Hematol. 2013;87(1):1–11.
   PubMed Web of Science ®Google Scholar
• Camerlingo R, Miceli R, Marra L, et al. Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation. PLoS One. 2019;14(7):e219597.
   PubMed Web of Science ®Google Scholar
• Shen Y, Chen Q, Li L. Endostar regulates EMT, migration and invasion of lung cancer cells through the HGF-Met pathway. Mol Cell Probes. 2019;45:57–64.
   PubMed Web of Science ®Google Scholar
• Pastushenko I, Blanpain C. EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 2019;29(3):212–226.
   PubMed Web of Science ®Google Scholar
• Wang JH, Lee EJ, Ji M, et al. HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells. Oncol Rep. 2018;40(1):346–354.
   PubMed Web of Science ®Google Scholar
• Li H, Wang Q, Wang Y, et al. Esculetin inhibits the proliferation of human lung cancer cells by targeting epithelial-to-mesenchymal transition of the cells. Cell Mol Biol (Noisy-le-grand). 2019;65(7):95–98.
   PubMed Web of Science ®Google Scholar
• Wang GH, Hu ZY. Department of cardio-thoracic surgery ZAHO. Icotinib inhibits proliferation and epithelial-mesenchymal transition of non-small cell lung cancer A549 cells. Math Biosci Eng. 2019;16(6):7707–7718.
   PubMed Web of Science ®Google Scholar
• Ghahhari NM, Babashah S. Interplay between microRNAs and WNT/beta-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. Eur J Cancer. 2015;51(12):1638–1649.
   PubMed Web of Science ®Google Scholar
• Wu C, Zhuang Y, Jiang S, et al. Interaction between Wnt/beta-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer (review). Int J Oncol. 2016;48(6):2236–2246.
   PubMed Web of Science ®Google Scholar
• Clevers H, Nusse R. Wnt/β-catenin signaling and disease. CELL. 2012;149(6):1192–1205.
   PubMed Web of Science ®Google Scholar
• Guo Y, Xiao L, Sun L, et al. Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res. 2012;149:337–346.
   Web of Science ®Google Scholar
• Zhang LN, Zhao L, Yan XL, et al. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/beta-catenin and PI3K/AKT signaling pathways. J Cell Physiol. 2019;234:20469–20484.
   PubMed Web of Science ®Google Scholar